Ang II increased the incidence of arrhythmias, especially during ischemia/reperfusion, and blockade of the Ang II type 1 receptor (AT1R) reduced the incidence of arrhythmias as well as mortality after MI [88]. The gene discussed is AGT; the disease is cardiac arrhythmia.